Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Identifieur interne : 002133 ( Main/Corpus ); précédent : 002132; suivant : 002134Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Auteurs : Gloria E. Meredith ; Un Jung KangSource :
- Movement Disorders [ 0885-3185 ] ; 2006-10.
English descriptors
- KwdEn :
Abstract
The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.21010
Links to Exploration step
ISTEX:BCA54866AC7BB617A1A5F02038F8B9099D979FB7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title><author><name sortKey="Meredith, Gloria E" sort="Meredith, Gloria E" uniqKey="Meredith G" first="Gloria E." last="Meredith">Gloria E. Meredith</name><affiliation><mods:affiliation>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Kang, Un Jung" sort="Kang, Un Jung" uniqKey="Kang U" first="Un Jung" last="Kang">Un Jung Kang</name><affiliation><mods:affiliation>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BCA54866AC7BB617A1A5F02038F8B9099D979FB7</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.21010</idno><idno type="url">https://api.istex.fr/document/BCA54866AC7BB617A1A5F02038F8B9099D979FB7/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002133</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title><author><name sortKey="Meredith, Gloria E" sort="Meredith, Gloria E" uniqKey="Meredith G" first="Gloria E." last="Meredith">Gloria E. Meredith</name><affiliation><mods:affiliation>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Kang, Un Jung" sort="Kang, Un Jung" uniqKey="Kang U" first="Un Jung" last="Kang">Un Jung Kang</name><affiliation><mods:affiliation>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-10">2006-10</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1595">1595</biblScope><biblScope unit="page" to="1606">1606</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">BCA54866AC7BB617A1A5F02038F8B9099D979FB7</idno><idno type="DOI">10.1002/mds.21010</idno><idno type="ArticleID">MDS21010</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>6‐OHDA</term><term>MPTP</term><term>Rotarod</term><term>adjusting steps</term><term>grid test</term><term>open field locomotion</term><term>pole test</term><term>rotation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Gloria E. Meredith PhD</name><affiliations><json:string>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</json:string></affiliations></json:item><json:item><name>Un Jung Kang MD</name><affiliations><json:string>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>open field locomotion</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>pole test</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>grid test</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Rotarod</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>rotation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>adjusting steps</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>6‐OHDA</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MPTP</value></json:item></subject><articleId><json:string>MDS21010</json:string></articleId><language><json:string>eng</json:string></language><abstract>The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society</abstract><qualityIndicators><score>7.376</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>8</keywordCount><abstractCharCount>1358</abstractCharCount><pdfWordCount>8577</pdfWordCount><pdfCharCount>55912</pdfCharCount><pdfPageCount>12</pdfPageCount><abstractWordCount>198</abstractWordCount></qualityIndicators><title>Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title><genre><json:string>review-article</json:string></genre><host><volume>21</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>12</total><last>1606</last><first>1595</first></pages><issn><json:string>0885-3185</json:string></issn><issue>10</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1002/mds.21010</json:string></doi><id>BCA54866AC7BB617A1A5F02038F8B9099D979FB7</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/BCA54866AC7BB617A1A5F02038F8B9099D979FB7/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/BCA54866AC7BB617A1A5F02038F8B9099D979FB7/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/BCA54866AC7BB617A1A5F02038F8B9099D979FB7/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2006</date></publicationStmt><notesStmt><note>USPHS - No. NS41799; No. NS32080; No. NS043286;</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title><author><persName><forename type="first">Gloria E.</forename><surname>Meredith</surname></persName><roleName type="degree">PhD</roleName><note type="correspondence"><p>Correspondence: Department of Cellular and Molecular Pharmacology, The Chicago Medical School/RFUMS, North Chicago, IL 60064</p></note><affiliation>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</affiliation></author><author><persName><forename type="first">Un Jung</forename><surname>Kang</surname></persName><roleName type="degree">MD</roleName><affiliation>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-10"></date><biblScope unit="volume">21</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1595">1595</biblScope><biblScope unit="page" to="1606">1606</biblScope></imprint></monogr><idno type="istex">BCA54866AC7BB617A1A5F02038F8B9099D979FB7</idno><idno type="DOI">10.1002/mds.21010</idno><idno type="ArticleID">MDS21010</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2006</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>open field locomotion</term></item><item><term>pole test</term></item><item><term>grid test</term></item><item><term>Rotarod</term></item><item><term>rotation</term></item><item><term>adjusting steps</term></item><item><term>6‐OHDA</term></item><item><term>MPTP</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2005-08-04">Received</change><change when="2006-03-12">Registration</change><change when="2006-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/BCA54866AC7BB617A1A5F02038F8B9099D979FB7/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="100"><doi origin="wiley" registered="yes">10.1002/mds.v21:10</doi><numberingGroup><numbering type="journalVolume" number="21">21</numbering><numbering type="journalIssue">10</numbering></numberingGroup><coverDate startDate="2006-10">October 2006</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="40" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21010</doi><idGroup><id type="unit" value="MDS21010"></id></idGroup><countGroup><count type="pageTotal" number="12"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Review</title></titleGroup><copyright ownership="thirdParty">Copyright © 2006 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2005-08-04"></event><event type="manuscriptRevised" date="2006-01-23"></event><event type="manuscriptAccepted" date="2006-03-12"></event><event type="publishedOnlineEarlyUnpaginated" date="2006-07-07"></event><event type="firstOnline" date="2006-07-07"></event><event type="publishedOnlineFinalForm" date="2006-10-20"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.18.1 mode:FullText source:FullText result:FullText" date="2010-09-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1595</numbering><numbering type="pageLast">1606</numbering></numberingGroup><correspondenceTo>Department of Cellular and Molecular Pharmacology, The Chicago Medical School/RFUMS, North Chicago, IL 60064</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21010.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="119"></count><count type="wordTotal" number="9623"></count></countGroup><titleGroup><title type="main" xml:lang="en">Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title><title type="short" xml:lang="en">Which Behavioral Test for PD Models?</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Gloria E.</givenNames><familyName>Meredith</familyName><degrees>PhD</degrees></personName><contactDetails><email>gloria.meredith@rosalindfranklin.edu</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Un Jung</givenNames><familyName>Kang</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">open field locomotion</keyword><keyword xml:id="kwd2">pole test</keyword><keyword xml:id="kwd3">grid test</keyword><keyword xml:id="kwd4">Rotarod</keyword><keyword xml:id="kwd5">rotation</keyword><keyword xml:id="kwd6">adjusting steps</keyword><keyword xml:id="kwd7">6‐OHDA</keyword><keyword xml:id="kwd8">MPTP</keyword></keywordGroup><fundingInfo><fundingAgency>USPHS</fundingAgency><fundingNumber>NS41799</fundingNumber><fundingNumber>NS32080</fundingNumber><fundingNumber>NS043286</fundingNumber></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Which Behavioral Test for PD Models?</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Behavioral models of Parkinson's disease in rodents: A new look at an old problem</title></titleInfo><name type="personal"><namePart type="given">Gloria E.</namePart><namePart type="family">Meredith</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA</affiliation><description>Correspondence: Department of Cellular and Molecular Pharmacology, The Chicago Medical School/RFUMS, North Chicago, IL 60064</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Un Jung</namePart><namePart type="family">Kang</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Departments of Neurology and Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2006-10</dateIssued><dateCaptured encoding="w3cdtf">2005-08-04</dateCaptured><dateValid encoding="w3cdtf">2006-03-12</dateValid><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">1</extent><extent unit="references">119</extent><extent unit="words">9623</extent></physicalDescription><abstract lang="en">The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the neuroanatomical substrates underlying motor control are similar for humans and rodents, the behavioral repertoire mediated by those circuits is not. The principal aim of this review is to evaluate how injury to dopamine‐mediated pathways in rodents gives rise to motor dysfunction that mimics human Parkinsonism. We will examine the behavioral tests in common use with rodent models of Parkinson's disease and critically evaluate the appropriateness of each test for detecting motor impairment. We will show how tests of motor performance must be guided by a thorough understanding of the clinical symptoms accompanying the disease, the circuitry mediating dopamine deficits in rodents, and familiarity with the rodent behavioral repertoire. We will explain how investigations in rodents of skilled forepaw actions, including placing, grooming, or foot faults, have clear correlates in Parkinson's disease, and are, therefore, the most sensitive ways of detecting motor impairment following dopamine loss from the basal ganglia of rodents. © 2006 Movement Disorder Society</abstract><note type="funding">USPHS - No. NS41799; No. NS32080; No. NS043286; </note><subject lang="en"><genre>Keywords</genre><topic>open field locomotion</topic><topic>pole test</topic><topic>grid test</topic><topic>Rotarod</topic><topic>rotation</topic><topic>adjusting steps</topic><topic>6‐OHDA</topic><topic>MPTP</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>1595</start><end>1606</end><total>12</total></extent></part></relatedItem><identifier type="istex">BCA54866AC7BB617A1A5F02038F8B9099D979FB7</identifier><identifier type="DOI">10.1002/mds.21010</identifier><identifier type="ArticleID">MDS21010</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2006 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002133 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002133 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:BCA54866AC7BB617A1A5F02038F8B9099D979FB7
|texte= Behavioral models of Parkinson's disease in rodents: A new look at an old problem
}}
| This area was generated with Dilib version V0.6.23. |  |